Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice

Jason T C Lee1, Iryna Shanina2, Yung Ning Chu1

  • 1Diabetes Research Group, UBC Life Sciences Institute, Department of Cellular and Physiological Sciences, Vancouver, BC, Canada.

Scientific Reports
|March 17, 2018
PubMed

Insights

Carbamazepine, a sodium channel blocker, reduced type 1 diabetes development by approximately 50% in non-obese diabetic mice. This treatment preserved functional pancreatic beta-cell mass, suggesting a potential therapeutic strategy for diabetes prevention.

Area of Science:

  • Immunology
  • Endocrinology
  • Pharmacology

Background:

  • Type 1 diabetes involves autoimmune destruction of pancreatic beta-cells.
  • Preserving beta-cell mass and function is crucial for preventing or slowing disease progression.
  • Carbamazepine, a sodium channel blocker, demonstrated in vitro protection of beta-cells from inflammatory cytokines.

Purpose of the Study:

  • To investigate the in vivo efficacy of carbamazepine in preventing type 1 diabetes.
  • To assess the impact of carbamazepine on beta-cell mass and function in a mouse model.

Main Methods:

  • Female non-obese diabetic (NOD) mice were fed a diet supplemented with carbamazepine (0.5% w/w).
  • Serum carbamazepine levels were maintained at approximately 15 µM.
  • Diabetes incidence was monitored via fasting blood glucose over 25 weeks.
  • Glucose tolerance and insulitis were assessed at 6 weeks of age.

Main Results:

  • Carbamazepine treatment reduced diabetes incidence by ~50% in NOD mice.
  • Improved glucose tolerance was observed in treated mice prior to diabetes onset.
  • Reduced insulitis was detected in carbamazepine-treated mice, indicating less pancreatic inflammation.

Conclusions:

  • Carbamazepine effectively reduces the development of type 1 diabetes in NOD mice.
  • The drug appears to maintain functional beta-cell mass, contributing to its protective effect.
  • Carbamazepine shows promise as a therapeutic agent for type 1 diabetes prevention.

Related Concept Videos

Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
1
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.1K